Alan Fligiel

Alan Fligiel ( ALAN FLIGIEL ) is A Dermatology Physician in Trenton, MI. The NPI Number for Alan Fligiel is 1285681486.

The current location address for Alan Fligiel is 1650 FORT STREET SUITE B Trenton, MI 48183 and the contact number is 7346763376 and fax number is 7346767162. The mailing address for Alan Fligiel is 1650 FORT STREET SUITE B Trenton, MI 48183- 7346763376 (mailing address contact number - 7346763376).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Alan Fligiel ?

Answer: The NPI Number for Alan Fligiel is 1285681486

Where is Alan Fligiel located?

Answer: Alan Fligiel is located at 1650 FORT STREET SUITE B Trenton, MI 48183.

What is the specialty for Alan Fligiel ?

Answer: The Specialty of Alan Fligiel is A Dermatology Physician.

Are there any online reviews for Alan Fligiel ?

Answer: Yes! Check It Now.

Are there any other health care providers in Trenton, MI?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Alan Fligiel

Number of HCPCS	24
Number of Medicare Beneficiaries	74
Number of Services	346
Total Submitted Charge Amount	31656
Total Medicare Allowed Amount	21066.56
Total Medicare Payment Amount	14963.49
Total Medicare Standardized Payment Amount	15632
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	75
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	38
Number of Beneficiaries Age 75 to 84
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	30
Number of Male Beneficiaries	44
Number of Non-Hispanic White Beneficiaries
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer
Percent (%) of Beneficiaries Identified With Heart Failure	0.16
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.31
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease
Percent (%) of Beneficiaries Identified With Depression	0.22
Percent (%) of Beneficiaries Identified With Diabetes	0.31
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.62
Percent (%) of Beneficiaries Identified With Hypertension	0.58
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.36
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.46
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders	0
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries	1.0605

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	90
Number of Standardized 30-Day Fills	93.466666667
Aggregate Cost Paid for All Claims	8652.71
Number of Day's Supply for All Claims	2247
Number of Medicare Beneficiaries	46
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	15
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	75
Aggregate Cost Paid for Generic Drugs	4565.23
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	30
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	5157.86
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	60
Aggregate Cost Paid for Claims Filled by	3494.85
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	74.086956522
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	22
Number of Male Beneficiaries	24
Number of Non-Hispanic White	43
Number of Black or African American	0
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.2760620466